Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep:16:22-27.
doi: 10.1016/j.vhri.2018.01.006. Epub 2018 Apr 4.

Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries

Alena N Skrundevskiy  1 , Omar S Omar  2 , Jungyoon Kim  3 , Amr S Soliman  4 , Theodore A Korolchuk  5 , Fernando A Wilson  1
Affiliations

Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries

Alena N Skrundevskiy et al. Value Health Reg Issues. 2018 Sep.

Abstract

Objective: The aim of this study was to perform a return-on-investment (ROI) analysis of a breast cancer screening program in Egypt by comparing net profit in treatment costs saved to program cost investment.

Methods: The breast cancer downstaging program targeted women living in an Egyptian slum, where residents have low access to health care. Program costs were estimated by using data from interviews with program administrative staff. Screening and treatment costs were estimated by using Ministry of Health medical reimbursement data. Estimates for expected rates of downstaging were modeled on the basis of data from a previous study. ROI, or relative cost savings, was calculated by comparing treatment cost savings to costs for the screening program. A baseline ROI for facility-based screening was calculated, followed by ROIs for different scenarios.

Results: Average per-person treatment cost for screened and unscreened patients was estimated to be $28,632 and $58,170, respectively, with a cumulative lifetime risk of 6.36%. Total screening program cost per person was $112.10. The study estimated an expected decrease in late-stage breast cancer diagnosis by 13.7% as a result of the screening program, saving $4,049 in treatment costs per individual diagnosed. The analysis resulted in a positive ROI of 133% for facility-based screening.

Conclusions: Breast cancer represents an increasing burden on health care in Egypt and other developing countries. This study concludes that a community-based downstaging program resulted in a positive ROI, or overall cost-savings. The findings inform that policymakers in low-income and middle-income countries may consider implementing community-based downstaging programs for breast cancer.

Keywords: Egypt; breast cancer; cancer screening; community; developing countries; downstaging; return-on-investment.

PubMed Disclaimer

Conflict of interest statement

The authors have indicated that they have no conflicts of interest with regard to the content of this article.

Figures

Fig. 1 -
Fig. 1 -
Result of univariate sensitivity analysis showing the impact of factors on return on investment for breast cancer screening in Egypt.
See this image and copyright information in PMC

References

    1. Azim HA, Ibrahim AS. Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis 2014;6(7):864–6. - PMC - PubMed
    1. Ibrahim AS, Khaled HM, Mikhail NN, et al. Cancer incidence in Egypt: results of the national population-based cancer registry program. J Cancer Epidemiol 2014;2014:1–18. - PMC - PubMed
    1. Hirko KA, Soliman AS, Hablas A, et al. Trends in breast cancer incidence rates by age and stage at diagnosis in Gharbiah, Egypt, over 10 years (1999–2008). J Cancer Epidemiol 2013;2013:1–7. - PMC - PubMed
    1. Globocan. Available from: http://globocan.iarc.fr/Default.aspx. [Accessed January 6, 2015].
    1. Sankaranarayanan R, Boffetta P. Research on cancer prevention, detection and management in low-and medium-income countries. Ann Oncol 2010;21(10):1935–43. - PubMed